Ventricular septal defect 1

Common Name(s)

Ventricular septal defect 1

Ventricular septal defect type 1 (VSD type 1) is a heart defect present at birth (congenital) in which there is a hole in the wall or septum that separates the ventricles (bottom two chambers of the heart). The septum separates oxygenated blood from deoxygenated blood. Normally, the holes in the septum close before the baby is born, but VSD is a common heart defect. In VSD Type 1, the hole occurs underneath the two arteries where blood leaves the heart (to either the lungs or to the body). If the hole is very small it may not affect how hard the heart has to work, and affected babies may not have symptoms. Sometimes a VSD is not diagnosed until childhood or even adulthood.

Often symptoms occur as soon as a few days after birth and include poor eating, fast breathing, breathlessness, and getting tired easily. VSDs often occur in families (hereditary) or with other genetic conditions. Type 1 is a less common type of VSD except in individuals of Asian descent where it accounts for about 1/3 of all VSDs. Medical researchers believe most VSDs are caused by a combination of genetic and environmental factors.

Doctors may hear a swishing sound in the heartbeat (a murmur) when listening with a stethoscope. Tests used to confirm a VSD may include a chest X-ray, electrocardiogram (EKG) (tests the electrical impulses), echocardiogram (used sound waves to create a picture), or cardiac MRI.

Medications may be used temporarily to increase heart function, but surgical repair is the most common treatment. Smaller defects may close on their own. If your baby or child has been diagnosed with a VSD, talk to their pediatric cardiologist (a heart doctor for children) about the most current treatment options. Support organizations and genetic counselors are also a good source of information and can help connect you with others affected by VSDs.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Ventricular septal defect 1" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Ventricular septal defect 1" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Ventricular septal defect 1" returned 3 free, full-text research articles on human participants. First 3 results:

Importance of plasma endothelin-1 level in the evaluation of heart failure severity in infants with ventricular septal defect.
 

Author(s): Jacek Skiendzielewski, Bo┼╝ena Werner

Journal: Kardiol Pol. 2014 ;72(5):459-64.

 

Haemodynamic disturbances due to ventricular septal defect (VSD) can lead to heart failure (HF) and cause neurohormonal activation. Endothelin-1 (ET-1) clearance takes place mainly in the pulmonary circulation. We hypothesized that increased pulmonary blood flow in children with VSD ...

Last Updated: 26 May 2014

Go To URL
Transpulmonary arterial repair of type 1 ventricular septal defect will induce pulmonary regurgitation: appraisal of subpulmonic approach.
 

Author(s): Shao-Ju Chien, Jen-Ping Chang, Chi-Di Liang, Ying-Jui Lin, Chien-Fu Huang, I-Chun Lin, Chiung-Lun Kao

Journal: J. Thorac. Cardiovasc. Surg.. 2011 Dec;142(6):1388-92.

 

A transpulmonary arterial approach to repair type I ventricular septal defect is the standard. However, the possible adverse effect on the pulmonary valve by this technique has not been investigated.

Last Updated: 18 Nov 2011

Go To URL

Last Updated: 5 Jun 2006

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Ventricular septal defect 1" returned 0 free, full-text review articles on human participants.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

There are currently no open clinical trials for this condition.